Postmarketing surveillance for human teratogenicity: A model approach

被引:60
作者
Chambers, CD
Braddock, SR
Briggs, GG
Einarson, A
Johnson, YR
Miller, RK
Polifka, JE
Robinson, LK
Stepanuk, K
Jones, KL
机构
[1] Univ Calif San Diego, Dept Pediat, Ctr Med, San Diego, CA 92103 USA
[2] Univ Missouri, Columbia, MO USA
[3] Long Beach Mem Med Ctr, Long Beach, CA USA
[4] Hosp Sick Children, Toronto, ON, Canada
[5] Childrens Hosp Michigan, Detroit, MI USA
[6] Univ Rochester, Ctr Med, Rochester, MI USA
[7] Univ Washington, Seattle, WA USA
[8] SUNY Buffalo, Buffalo, NY USA
[9] Thomas Jefferson Univ, Philadelphia, PA USA
关键词
D O I
10.1002/tera.1071
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Most congenital defects associated with prenatal exposures are notable for a pattern of major and minor malformations, rather than for a single major malformation. Thus, traditional epidemiological methods are not universally effective in identifying new teratogens. The purpose of this report is to outline a complementary approach that can be used in addition to other more established methods to provide the most comprehensive evaluation of prenatal exposures with respect to teratogenicity. Methods: We describe a multicenter prospective cohort study design involving dysmorphological assessment of liveborn infants. This design uses the Organization of Teratology Information Services, a North American network of information providers who also collaborate for research purposes. Procedures for subject selection, methods for data collection, standard criteria for outcome classification, and the approach to analysis are detailed. Results: The focused cohort study design allows for evaluation of a spectrum of adverse pregnancy outcomes ranging from spontaneous abortion to functional deficit. While sample sizes are typically inadequate to identify increased risks for single major malformations, the use of dysmorphological examinations to classify structural anomalies provides the unique advantage of screening for a pattern of malformation among exposed infants. Conclusions: As the known human teratogens are generally associated with patterns of structural defects, it is only when studies of this type are used in combination with more traditional methods that we can achieve an acceptable level of confidence regarding the risk or safety of specific exposures during pregnancy. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:252 / 261
页数:10
相关论文
共 46 条
  • [1] Aase J. M., 1990, DIAGNOSTIC DYSMORPHO
  • [2] DEVELOPMENTAL NEUROTOXICITY OF ANTICONVULSANTS - HUMAN AND ANIMAL EVIDENCE ON PHENYTOIN
    ADAMS, J
    VORHEES, CV
    MIDDAUGH, LD
    [J]. NEUROTOXICOLOGY AND TERATOLOGY, 1990, 12 (03) : 203 - 214
  • [3] [Anonymous], 1982, CASE CONTROL STUDIES
  • [4] Reporting bias in retrospective ascertainment of drug-induced embryopathy
    Bar-Oz, B
    Moretti, ME
    Mareels, G
    Van Tittelboom, T
    Koren, G
    [J]. LANCET, 1999, 354 (9191) : 1700 - 1701
  • [5] Chronicity, severity, and timing of maternal depressive symptoms: Relationships with child outcomes at age 5
    Brennan, PA
    Hammen, C
    Andersen, MJ
    Bor, W
    Najman, JM
    Williams, GM
    [J]. DEVELOPMENTAL PSYCHOLOGY, 2000, 36 (06) : 759 - 766
  • [6] Brent RL, 2001, TERATOLOGY, V63, P106
  • [7] Breslow NE, 1987, STAT METHODS CANC RE, VII
  • [8] Carlin JB, 2000, TERATOLOGY, V62, P406, DOI 10.1002/1096-9926(200012)62:6<406::AID-TERA7>3.3.CO
  • [9] 2-5
  • [10] Birth outcomes in pregnant women taking fluoxetine
    Chambers, CD
    Johnson, KA
    Dick, LM
    Felix, RJ
    Jones, KL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1010 - 1015